Stay updated with breaking news from Yuling Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Zhejiang Innoforce Pharmaceuticals Co., Ltd. ("Innoforce"), a CDMO company dedicated to providing one-stop-shop services to Advanced Therapy...
/PRNewswire/ -- Innoforce, a global provider of end-to-end contract development and manufacturing services (CDMO), today announced that it commenced GMP...
/PRNewswire/ -- Innoforce, a global provider of end-to-end contract development and manufacturing services (CDMO), today announced that it commenced GMP...
The company had raised 170 million yuan ($24 million) in a Pre-A funding round in June last year.
Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics News provided by Share this article Share this article HANGZHOU, China and SHANGHAI, March 2, 2021 /PRNewswire/ -- Innoforce, a biopharmaceutical innovation enabling platform and PDMO (Partner Development and Manufacturing Organization), and dMed, a clinical CRO with strong presence in China and the US - the world's two largest pharmaceutical and drug development markets, have signed an agreement under which the two parties agreed to establish a partnership to identify, assess, and collaborate on the dev...